Access to medicines
MSF launches global campaign urging Johnson & Johnson to reduce price of life-saving TB drug
Press Release
11 Oct 2019
Too often we cannot treat patients because the medicines are too expensive, or they are no longer produced. Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure.
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases.